Abingdon Health Plc (ABDX) - Total Assets
Based on the latest financial reports, Abingdon Health Plc (ABDX) holds total assets worth GBX10.55 Million GBX (≈ $1.28K USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Abingdon Health Plc - Total Assets Trend (2016–2025)
This chart illustrates how Abingdon Health Plc's total assets have evolved over time, based on quarterly financial data. Also see market value of Abingdon Health Plc for the company's overall valuation and market capitalisation.
Abingdon Health Plc - Asset Composition Analysis
Current Asset Composition (June 2025)
Abingdon Health Plc's total assets of GBX10.55 Million consist of 55.1% current assets and 44.9% non-current assets. Review ABDX liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 20.6% |
| Accounts Receivable | GBX2.69 Million | 28.8% |
| Inventory | GBX526.00K | 5.7% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX504.00K | 5.4% |
| Goodwill | GBX2.28 Million | 24.5% |
Asset Composition Trend (2016–2025)
This chart illustrates how Abingdon Health Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Abingdon Health Plc (ABDX) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Abingdon Health Plc's current assets represent 55.1% of total assets in 2025, an increase from 41.2% in 2016.
- Cash Position: Cash and equivalents constituted 20.6% of total assets in 2025, down from 23.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 29.0% of total assets, a decrease from 53.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 28.8% of total assets.
Abingdon Health Plc Competitors by Total Assets
Key competitors of Abingdon Health Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
LONZA GROUP UNSP.ADR 1/10
F:LO3A
|
Germany | €17.91 Billion |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €88.84 Million |
|
Gencurix Inc
KQ:229000
|
Korea | ₩31.09 Billion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
Abingdon Health Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.91 | 2.55 | 3.44 |
| Quick Ratio | 1.73 | 2.36 | 2.78 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX3.20 Million | GBX3.75 Million | GBX21.59 Million |
Abingdon Health Plc - Advanced Valuation Insights
This section examines the relationship between Abingdon Health Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.08 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 83.0% |
| Total Assets | GBX9.31 Million |
| Market Capitalization | $320.76K USD |
Valuation Analysis
Below Book Valuation: The market values Abingdon Health Plc's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Abingdon Health Plc's assets grew by 83.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Abingdon Health Plc (2016–2025)
The table below shows the annual total assets of Abingdon Health Plc from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | GBX9.31 Million ≈ $1.13K |
+82.97% |
| 2024-06-30 | GBX5.09 Million ≈ $619.31 |
-16.02% |
| 2023-06-30 | GBX6.06 Million ≈ $737.45 |
-52.54% |
| 2022-06-30 | GBX12.77 Million ≈ $1.55K |
-61.56% |
| 2021-06-30 | GBX33.23 Million ≈ $4.04K |
+202.94% |
| 2020-06-30 | GBX10.97 Million ≈ $1.33K |
+49.67% |
| 2019-06-30 | GBX7.33 Million ≈ $891.64 |
+5.87% |
| 2018-06-30 | GBX6.92 Million ≈ $842.23 |
-19.54% |
| 2016-12-31 | GBX8.60 Million ≈ $1.05K |
-- |
About Abingdon Health Plc
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant heal… Read more